- Home
- Publications
- Publication Search
- Publication Details
Title
Brivaracetam: An Adjunctive Treatment for Partial-Onset Seizures
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL PHARMACOLOGY
Volume 57, Issue 7, Pages 811-817
Publisher
Wiley
Online
2017-04-10
DOI
10.1002/jcph.900
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Safety and tolerability of adjunctive brivaracetam as intravenous infusion or bolus in patients with epilepsy
- (2016) Pavel Klein et al. EPILEPSIA
- Safety, tolerability, and seizure control during long-term treatment with adjunctive brivaracetam for partial-onset seizures
- (2016) Manuel Toledo et al. EPILEPSIA
- Brivaracetam add-on for refractory focal epilepsy
- (2016) Simona Lattanzi et al. NEUROLOGY
- Efficacy and safety of brivaracetam for partial-onset seizures in 3 pooled clinical studies
- (2016) Elinor Ben-Menachem et al. NEUROLOGY
- Levetiracetam vs. brivaracetam for adults with refractory focal seizures: A meta-analysis and indirect comparison
- (2016) Lin Zhang et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- A randomized, double-blind, placebo-controlled, multicenter, parallel-group study to evaluate the efficacy and safety of adjunctive brivaracetam in adult patients with uncontrolled partial-onset seizures
- (2015) Pavel Klein et al. EPILEPSIA
- Brivaracetam and carbamazepine interaction in healthy subjects and in vitro
- (2015) Armel Stockis et al. EPILEPSY RESEARCH
- ILAE Official Report: A practical clinical definition of epilepsy
- (2014) Robert S. Fisher et al. EPILEPSIA
- Interaction between brivaracetam (100 mg/day) and a combination oral contraceptive: A randomized, double-blind, placebo-controlled study
- (2014) Armel Stockis et al. EPILEPSIA
- Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: A phase III randomized, double-blind, placebo-controlled trial
- (2013) Victor Biton et al. EPILEPSIA
- Adjunctive brivaracetam for uncontrolled focal and generalized epilepsies: Results of a phase III, double-blind, randomized, placebo-controlled, flexible-dose trial
- (2013) Patrick Kwan et al. EPILEPSIA
- Adjunctive brivaracetam in adults with uncontrolled focal epilepsy: Results from a double-blind, randomized, placebo-controlled trial
- (2013) Philippe Ryvlin et al. EPILEPSIA
- Effect of brivaracetam (400 mg/day) on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive in healthy women
- (2013) Armel Stockis et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Brivaracetam Disposition in Mild to Severe Hepatic Impairment
- (2013) Armel Stockis et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Efficacy and tolerability of adjunctive brivaracetam in adults with uncontrolled partial-onset seizures: A phase IIb, randomized, controlled trial
- (2012) Wim Van Paesschen et al. EPILEPSIA
- Epilepsy across the spectrum: Promoting health and understanding.
- (2012) Mary Jane England et al. EPILEPSY & BEHAVIOR
- Brivaracetam Disposition in Renal Impairment
- (2012) Maria Laura Sargentini-Maier et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Binding characteristics of brivaracetam, a selective, high affinity SV2A ligand in rat, mouse and human brain: Relationship to anti-convulsant properties
- (2011) Michel Gillard et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Adjunctive brivaracetam for refractory partial-onset seizures: A randomized, controlled trial
- (2010) J. A. French et al. NEUROLOGY
- Brivaracetam (ucb 34714) inhibits Na+ current in rat cortical neurons in culture
- (2009) Cristina Zona et al. EPILEPSY RESEARCH
- Anti-convulsive and anti-epileptic properties of brivaracetam (ucb 34714), a high-affinity ligand for the synaptic vesicle protein, SV2A
- (2008) A Matagne et al. BRITISH JOURNAL OF PHARMACOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started